Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)
China flag China · Delayed Price · Currency is CNY
44.30
+0.34 (0.77%)
Sep 4, 2026, 3:00 PM CST

SHA:688580 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
168.87138.07101.97136.2693.83177.81
Depreciation & Amortization
26.5327.2721.9820.1417.1411.08
Other Amortization
1.932.021.431.841.680.38
Loss (Gain) From Sale of Assets
-33.170-00--
Asset Writedown & Restructuring Costs
0.22-0.010.010.010.01
Loss (Gain) From Sale of Investments
-16.61-17.37-13.76-9.62-16.01-20.56
Provision & Write-off of Bad Debts
0.840.841.442.270.680.89
Other Operating Activities
1.041.731.181.240.33-0.09
Change in Accounts Receivable
-42.64-35.67.77-21.777.32-13.14
Change in Inventory
-0.31-3.91.15-5.081.816.67
Change in Accounts Payable
59.3461.71-9.17-3.48-20.13-18.96
Change in Other Net Operating Assets
3.992.483.4719.65-2.8321.37
Operating Cash Flow
171.22176.74118.29134.286.17157.37
Operating Cash Flow Growth
13.44%49.42%-11.86%55.74%-45.24%30.31%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-154.41-118.12-113.08-133.48-95.61-87.34
Sale of Property, Plant & Equipment
108.2841.650.020--
Cash Acquisitions
-29.65-29.65--20.11-34.19-
Investment in Securities
-149.96-49.96--23--
Other Investing Activities
10.7212.5812.2412.4825.0110.56
Investing Cash Flow
-215.01-143.49-100.82-164.11-104.8-76.79

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.88-1.55-1.35-14.87-1.35
Net Debt Issued (Repaid)
-0.88-0.88-1.55-1.35-14.87-1.35
Issuance of Common Stock
--13.32-10.79-
Repurchase of Common Stock
---13.64-11.58-2.02-
Common Dividends Paid
-102.89-76.57-102.2-51.04-88.91-71.83
Dividends Paid
-102.89-76.57-102.2-51.04-88.91-71.83
Other Financing Activities
0.11-----7.81
Financing Cash Flow
-103.66-77.45-104.07-63.96-95.01-80.99

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.16-0.040---
Net Cash Flow
-147.61-44.24-86.59-93.87-113.64-0.41

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
16.8158.635.210.72-9.4570.02
Free Cash Flow Growth
-63.94%1024.89%627.46%---35.82%
Free Cash Flow Margin
3.51%12.67%1.30%0.15%-2.94%16.28%
Free Cash Flow Per Share
0.180.610.060.01-0.100.73
Levered Free Cash Flow
-94.6521.738.41-26.08-15.43-4.02
Unlevered Free Cash Flow
-93.8322.559.23-25.26-15.22-3.91

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
44.6535.6844.5241.8240.1250.52
Change in Working Capital
21.5724.174.05-17.94-11.5-12.16